An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

December 15, 2024

Study Completion Date

December 30, 2024

Conditions
Respiratory Tract Infections
Interventions
DIAGNOSTIC_TEST

MeMed BV® biomarker test

one purple top tube of whole blood (2-3 cc) to be used for the MeMed Key® device processing without the need for centrifuge. The MeMed BV® test takes approximately 15 minutes to process and result. After, the sample has been processed and the MeMed BV® test has resulted, the sample of blood will be discarded for each patient enrolled in the study.

DIAGNOSTIC_TEST

Usual care

Usual care includes diagnostic hematology, chemistry, biomarkers, and culture results along with imaging, consults, and medications, in the treatment of acute viral and/or bacterial illness.

Trial Locations (1)

77030

RECRUITING

The University of Texas Health Science Center at Houston, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MeMed Diagnostics Ltd.

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER